Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?

There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41

Detalles Bibliográficos
Autores principales: Guariglia, Andrea, Davies, Iona J., Kanellakis, Nikolaos I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792827/
https://www.ncbi.nlm.nih.gov/pubmed/33447290
http://dx.doi.org/10.1183/20734735.0204-2020
_version_ 1783633871426813952
author Guariglia, Andrea
Davies, Iona J.
Kanellakis, Nikolaos I.
author_facet Guariglia, Andrea
Davies, Iona J.
Kanellakis, Nikolaos I.
author_sort Guariglia, Andrea
collection PubMed
description There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41
format Online
Article
Text
id pubmed-7792827
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-77928272021-01-13 Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Guariglia, Andrea Davies, Iona J. Kanellakis, Nikolaos I. Breathe (Sheff) Expert Opinion There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41 European Respiratory Society 2020-12 /pmc/articles/PMC7792827/ /pubmed/33447290 http://dx.doi.org/10.1183/20734735.0204-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Expert Opinion
Guariglia, Andrea
Davies, Iona J.
Kanellakis, Nikolaos I.
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
title Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
title_full Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
title_fullStr Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
title_full_unstemmed Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
title_short Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
title_sort evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792827/
https://www.ncbi.nlm.nih.gov/pubmed/33447290
http://dx.doi.org/10.1183/20734735.0204-2020
work_keys_str_mv AT guarigliaandrea evaluationofcardiovascularriskinalungcancerscreeningcohortwhatvaluedoesitbring
AT daviesionaj evaluationofcardiovascularriskinalungcancerscreeningcohortwhatvaluedoesitbring
AT kanellakisnikolaosi evaluationofcardiovascularriskinalungcancerscreeningcohortwhatvaluedoesitbring

Ejemplares similares